BriaCell Therapeutics Corp.
BCTX
$2.02
-$0.05-2.42%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1,231.66% | -19.71% | -57.55% | -95.94% | -96.68% |
| Total Receivables | 15,195.39% | 7,039.20% | 11,240.19% | -- | 2.01% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -63.92% | 247.43% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 167.36% | -39.00% | -55.35% | -86.44% | -81.26% |
|
|
|||||
| Total Current Assets | 167.36% | -39.00% | -55.35% | -86.44% | -81.26% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -7.51% | -7.33% | -7.24% | -7.11% | -6.99% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 174.08% | -23.44% | -44.07% | -78.38% | -79.13% |
|
|
|||||
| Total Accounts Payable | -48.94% | 34.80% | 875.80% | 538.14% | 545.27% |
| Total Accrued Expenses | 213.48% | 6.90% | 23.20% | -57.15% | -13.51% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -35.92% | 33.29% | 376.69% | 314.17% | 388.60% |
|
|
|||||
| Total Current Liabilities | -35.92% | 33.29% | 376.69% | 314.17% | 388.60% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -87.14% | -94.55% | -88.62% | -96.24% | -83.41% |
| Total Liabilities | -59.31% | -70.14% | -58.38% | -72.34% | -65.08% |
|
|
|||||
| Common Stock & APIC | 35.11% | 22.79% | 5.84% | 3.70% | -3.98% |
| Retained Earnings | -23.07% | -13.49% | -22.23% | -5.94% | -7.66% |
| Treasury Stock & Other | 154.33% | 89.47% | 9,651.41% | 49.59% | 6,352.85% |
| Total Common Equity | 308.13% | 144.63% | 48.55% | 36.93% | -1.24% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 308.13% | 144.63% | 48.55% | 36.93% | -1.24% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -76.97% | -53.85% | -60.70% | -- | -- |
| Total Equity | 291.58% | 138.80% | 47.56% | 28.92% | -5.78% |
|
|
|||||